Skip to content
2000
Volume 16, Issue 2
  • ISSN: 1574-3624
  • E-ISSN: 2212-389X

Abstract

The serum and glucocorticoid inducible protein kinase (SGK) family signals downstream of phosphoinositide-3-kinase (PI3K) and is made up of three isoforms: SGK1, 2, and 3. respectively, and their activity is dependent on growth factor activation. Among these SGK families, one such potential target and a less explored enzyme is SGK3. SGK3 regulates a range of basic cellular processes, such as cell proliferation, migration and survival, thus playing an important role in cancer development. These kinase-signaling pathways present both opportunities and challenges for cancer therapy. In this paper, we reviewed the status of SGK3 regulation and its role in normal cell physiology and transformation. In addition, the potential roles of SGK3 signal transduction in breast cancer and prostate cancer are discussed.

Loading

Article metrics loading...

/content/journals/cst/10.2174/1574362415666200203122829
2021-08-01
2025-09-20
Loading full text...

Full text loading...

/content/journals/cst/10.2174/1574362415666200203122829
Loading

  • Article Type:
    Research Article
Keyword(s): AKT; breast cancer; INPP4B; mTOR; PI3K; prostate cancer; SGK3
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test